Delivery Order SPE2DB24D2100-SPE2DB25FBDQK
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,337.28 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,951,758 units of the prescription medication Fexofenadine HCL 180 mg tablets. There is no set-aside designation, indicating open competition. The contract has an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,010.19, is a delivery order for the supply of Fexofenadine HCL 180 mg tablets. It is a firm fixed-price contract with a completion date of February 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a $2,501.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,198,982 units of fexofenadine HCl 180 mg tablets. The contract has an ultimate completion date of February 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,760.02 firm fixed price contract provides 4,562,878,752 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,533 units of Fexofenadine HCL 180 mg tablets. The $1,340.43 ceiling value contract has a completion date of September 21, 2022. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov) until June 2025, has an extensive history of providing pharmaceutical and medical products...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,704 units of Fexofenadine Hydrochloride 180 mg tablets, valued at $1,307.79, with a completion date of December 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.44, is for the delivery of Fexofenadine HCL 180 mg Tablets. This is a firm fixed-price delivery order contract with a completion date of May 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,272,960 units of Fexofenadine HCL 180 mg tablets, a medication used to treat allergies. The contract has a ceiling value of $1,216.68 and a completion date of September 25, 2023. This contract is a delivery order and is priced as a firm-fixed price. AmerisourceBergen holds a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,673.88 firm fixed-price delivery order is for the supply of 4,567,886,379 units of the drug Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of April 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,390.41, is for the procurement of fexofenadine hydrochloride 180 mg tablets, a prescription medication. The contract has an ultimate completion date of July 11, 2024 and is a firm fixed-price delivery order. The award is not associated with a set-aside designation, indicating open competition....